Insider Transactions in Q4 2020 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
David P Schenkein Director |
SELL
Open market or private sale
|
Indirect |
5,000
-16.01%
|
$450,000
$90.01 P/Share
|
|
Dec 21
2020
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$2,250,000
$90.06 P/Share
|
|
Dec 21
2020
|
Douglas K Bratton > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
383,411
-100.0%
|
-
|
|
Dec 14
2020
|
Douglas K Bratton > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,825
-2.23%
|
$1,426,000
$80.74 P/Share
|
|
Dec 11
2020
|
Douglas K Bratton > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
46,799
-10.45%
|
$3,743,920
$80.05 P/Share
|
|
Nov 12
2020
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
30,000
-54.55%
|
$2,100,000
$70.05 P/Share
|
|
Nov 10
2020
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
10,000
-15.38%
|
$600,000
$60.03 P/Share
|
|
Nov 04
2020
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
10,000
-13.33%
|
$500,000
$50.18 P/Share
|
|
Oct 09
2020
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
30,000
-7.91%
|
$1,230,000
$41.09 P/Share
|
|
Oct 09
2020
|
Carole Ho Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
30,000
+13.24%
|
$150,000
$5.28 P/Share
|
|
Oct 08
2020
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
22,906
-12.09%
|
$916,240
$40.12 P/Share
|
|
Oct 08
2020
|
Carole Ho Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
22,906
+10.78%
|
$114,530
$5.28 P/Share
|